Saltar al contenido
Merck

Human PAD4 regulates histone arginine methylation levels via demethylimination.

Science (New York, N.Y.) (2004-09-04)
Yanming Wang, Joanna Wysocka, Joyce Sayegh, Young-Ho Lee, Julie R Perlin, Lauriebeth Leonelli, Lakshmi S Sonbuchner, Charles H McDonald, Richard G Cook, Yali Dou, Robert G Roeder, Steven Clarke, Michael R Stallcup, C David Allis, Scott A Coonrod
RESUMEN

Methylation of arginine (Arg) and lysine residues in histones has been correlated with epigenetic forms of gene regulation. Although histone methyltransferases are known, enzymes that demethylate histones have not been identified. Here, we demonstrate that human peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. PAD4 targets multiple sites in histones H3 and H4, including those sites methylated by coactivators CARM1 (H3 Arg17) and PRMT1 (H4 Arg3). A decrease of histone Arg methylation, with a concomitant increase of citrullination, requires PAD4 activity in human HL-60 granulocytes. Moreover, PAD4 activity is linked with the transcriptional regulation of estrogen-responsive genes in MCF-7 cells. These data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
PADI-4 human, recombinant, expressed in baculovirus infected Sf9 cells, ≥65% (SDS-PAGE)